Douglas H. Thamm
Chief Tech/Sci/R&D Officer at Csu Flint Animal Cancer Center
Profile
Douglas H.
Thamm is currently the Director of Clinical Research at CSU Flint Animal Cancer Center, Head of Clinical Development at VetDC, Inc., and a Member of the Cell & Molecular Biology Graduate Program at Colorado State University.
He received his undergraduate and doctorate degrees from the University of Pennsylvania.
Douglas H. Thamm active positions
| Companies | Position | Start |
|---|---|---|
VetDC, Inc.
 VetDC, Inc. Agricultural Commodities/MillingProcess Industries VetDC, Inc. develops cancer drugs for pets. It is a cancer-focused veterinary biopharmaceutical company developing innovative, underutilized human technologies for use in companion animals. It offers VDC-1101, a novel anti-cancer pro-drug from Gilead Sciences for use in animal cancer. The company was founded by Terry J. Opgenorth in 2009 and is headquartered in Fort Collins, CO. | Corporate Officer/Principal | - |
| Csu Flint Animal Cancer Center | Chief Tech/Sci/R&D Officer | - |
| Colorado State University | Corporate Officer/Principal | - |
Training of Douglas H. Thamm
| University of Pennsylvania | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
VetDC, Inc.
VetDC, Inc. Agricultural Commodities/MillingProcess Industries VetDC, Inc. develops cancer drugs for pets. It is a cancer-focused veterinary biopharmaceutical company developing innovative, underutilized human technologies for use in companion animals. It offers VDC-1101, a novel anti-cancer pro-drug from Gilead Sciences for use in animal cancer. The company was founded by Terry J. Opgenorth in 2009 and is headquartered in Fort Collins, CO. | Process Industries |
| Csu Flint Animal Cancer Center |
- Stock Market
- Insiders
- Douglas H. Thamm
